Profiling three-dimensional nuclear telomeric architecture of myelodysplastic syndromes and acute myeloid leukemia defines patient subgroups (2012)
- Authors:
- USP affiliated authors: REGO, EDUARDO MAGALHÃES - FMRP ; FALCÃO, ROBERTO PASSETTO - FMRP
- Unidade: FMRP
- DOI: 10.1158/1078-0432.CCR-12-0087
- Subjects: LEUCEMIA MIELOIDE AGUDA; MEDULA ÓSSEA; NÚCLEO CELULAR; ESTUDOS DE COORTES
- Language: Inglês
- Imprenta:
- Publisher place: Philadelphia
- Date published: 2012
- Source:
- Título do periódico: Clinical Cancer Research
- ISSN: 1078-0432
- Volume/Número/Paginação/Ano: v. 18, n. 12, p. 3293-3304, 2012
- Este periódico é de assinatura
- Este artigo é de acesso aberto
- URL de acesso aberto
- Cor do Acesso Aberto: green
- Licença: other-oa
-
ABNT
GADJI, Macoura et al. Profiling three-dimensional nuclear telomeric architecture of myelodysplastic syndromes and acute myeloid leukemia defines patient subgroups. Clinical Cancer Research, v. 18, n. 12, p. 3293-3304, 2012Tradução . . Disponível em: https://doi.org/10.1158/1078-0432.CCR-12-0087. Acesso em: 23 abr. 2024. -
APA
Gadji, M., Awe, J. A., Rodrigues, P., Kumar, R., Houston, D. S., Klewes, L., et al. (2012). Profiling three-dimensional nuclear telomeric architecture of myelodysplastic syndromes and acute myeloid leukemia defines patient subgroups. Clinical Cancer Research, 18( 12), 3293-3304. doi:10.1158/1078-0432.CCR-12-0087 -
NLM
Gadji M, Awe JA, Rodrigues P, Kumar R, Houston DS, Klewes L, Dièye TN, Rego EM, Passetto RF, Oliveira FM de, Mai S. Profiling three-dimensional nuclear telomeric architecture of myelodysplastic syndromes and acute myeloid leukemia defines patient subgroups [Internet]. Clinical Cancer Research. 2012 ; 18( 12): 3293-3304.[citado 2024 abr. 23 ] Available from: https://doi.org/10.1158/1078-0432.CCR-12-0087 -
Vancouver
Gadji M, Awe JA, Rodrigues P, Kumar R, Houston DS, Klewes L, Dièye TN, Rego EM, Passetto RF, Oliveira FM de, Mai S. Profiling three-dimensional nuclear telomeric architecture of myelodysplastic syndromes and acute myeloid leukemia defines patient subgroups [Internet]. Clinical Cancer Research. 2012 ; 18( 12): 3293-3304.[citado 2024 abr. 23 ] Available from: https://doi.org/10.1158/1078-0432.CCR-12-0087 - Downregulation of MDR1/P-glycoprotein preceeds overt acute promyelocytic leukemia in PML-RAR'alfa' transgenic mouse models
- Segmental amplification of MLL gene associated with high expression of AURKA and AURKB genes in a case of acute monoblastic leukemia with complex karyotype
- Diminuição da função da P-gp precede o desenvolvimento da Leucemia Promielocítica aguda em camundongos trangênicos PML-RAR'alfa'
- Leucemia linfocítica crônica biclonal
- P-gp function and expression in decreased in hCG-PML-RAR'alfa' transgenic mice before the development of leukemia
- High expression of AURKA and AURKB is associated with unfavorable cytogenetic abnormalities and high white blood cell count in patients with acute myeloid leukemia
- Linfomas de células T e NK
- FISH analysis for TET2 deletion in a cohort of 362 Brazilian myeloid malignancies: correlation with karyotype abnormalities
- The microgranular variant of acute promyelocytic leukemia also presents the flow cytometric pattern of CD13, CD34 and CD15 expression characteristic of PML-RAR'alfa' gene rearrangement
- Asynchronous expression of myeloid antigens in leukemic cells in a PML/RARa transgenic mouse model
Informações sobre o DOI: 10.1158/1078-0432.CCR-12-0087 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
